ARTIFICIAL INSEMINATION IN FARM ANIMALS - Phenix-Vet

Reproductive Endocrinology Diseases: Hormone Replacement and Therapy for Peri/Menopause 295agonist treatments in postmenopausal women, J Clin Endocrinol Metab 75:820,1992.McIlveen M, Skull JD, Ledger WL, Evaluation of the utility of multiple endocrine andultrasound measures of ovarian reserve in the prediction of cycle cancellation in ahigh-risk IVF population, Hum Reprod 22:778, 2007.McKinlay SM, Brambilla DJ, Posner JG: The normal menopause transition. Am J Hum Biol.;4:37-46. 1992.McLachlan RI, Robertson DM, Healy DL, de Kretser DM, Burger HG Plasma inhibin levelsduring gonadotropin-induced ovarian hyper stimulation for IVF: a new index offollicular function? Lancet 1:1233–1234. 1986.Messinis IE, Milingos SD, Future use of clomiphene in ovarian stimulation. Clomiphene inthe 21st century, Hum Reprod 13:2362, 1998.Meyer PM, Zeger SL, Harlow SD, Sowers M, Crawford S, Luborsky JL, Janssen I, McConnellDS, Randolph JF, Weiss G, Characterizing daily urinary hormone profi les forwomen at midlife using functional data analysis, Am J Epidemiol 165:936, 2007.Millar R: Brain Peptides Section. In: Kastin AJ, ed. Handbook on Biologically ActivePeptides, Burlington, MA: Elsevier;:635-644. 2005.Millar RP, Lu Z-L, Pawson AJ, et al: Gonadotropin-releasing hormone receptors. EndocrRev; 25(2):235-275. 2004.Millar RP: Gonadotropin-releasing hormones and their receptors. In: Fauser BCJM, ed.Reproductive medicine: molecular cellular and genetic fundamentals, Lancaster:Parthenon Publishing; 2002:199-224.Munster K, Schmidt L, Helm P, Length and variation in the menstrual cycle—a crosssectionalstudy from a Danish county, Br J Obstet Gynaecol 99:422, 1992.Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Elsner CW, Mitchell-Leef D, Toledo AA, KortHI, Clinical evaluation of the efficiency of an oocyte donation program using eggcryo-banking, Fertil Steril 92:520, 2009.Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S, Cumulative conceptionand live birth rates in natural (unstimulated) IVF cycles, Hum Reprod 16:259, 2001.Nilsson E, Rogers N, Skinner MK, Actions of anti-Mullerian hormone on the ovariantranscriptome to inhibit primordial to primary follicle transition, Reproduction134:209, 2007.Noyes N, Porcu E, Borini A, Over 900 oocyte cryopreservation babies born with no apparentincrease in congenital anomalies, Reprod Biomed Online 18:769, 2009.Oktay K, Cil AP, Bang H, Effi ciency of oocyte cryopreservation: a meta-analysis, Fertil i R,Seracchioli R, Ciotti PM, Magrini O, Flamigni C, Birth of a healthy female afterintracytoplasmic sperm injection of cryopreserved human oocytes, Fertil Steril68:724, 1997.Olivennes F, Alvarez S, Bouchard P, Fanchin R, Salat-Baroux J, Frydman R, The use of aGnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: adose fi nding study of 3 versus 2 mg, Hum Reprod 13:2411, 1998.Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, Nicollet B,Zorn JR, Bouchard P, Frydman R, Prospective, randomized, controlled study of invitro fertilization-embryo transfer with a single dose of a luteinizing hormone-